Fig. 7From: Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flowSchematic diagram of the possible mechanism underlying methotrexate (MTX)-mediated protection of HUVECs against disturbed flow (DF) injury via the activation of AMPK-YAP/TAZ signallingBack to article page